Fundraising Fox

Coherus Biosciences

2 known investors

coherus.com ↗

Coherus Oncology develops and commercializes immuno-oncology therapies, including the approved LOQTORZI, to treat patients with cancer. The company focuses on expanding its pipeline of clinical-stage candidates targeting the tumor microenvironment.

BiotechHealthtechMedical Devices

Investors · 2

F-Prime Capital PartnersBoston
Sofinnova VenturesMenlo Park

In the news